Skip to Content

Notice

Designation of ONDCP SES Performance Review Board Members

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Office of National Drug Control Policy.

ACTION:

Notice of Designation of ONDCP SES Performance Review Board.

Headings: Designation Pursuant of ONDCP SES Performance Review Board Pursuant to 5 CFR 4 30.310.

SUMMARY:

The Director of the Office of National Drug Control Policy has appointed Patrick M. Ward, Robert Denniston, Michele Marx, and Jeffrey Teitz as members of the ONDCP SES Performance Review Board (PRB).

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Please direct any questions to Briggitte LaFontant, Assistant for Personnel, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20502; (202) 395-6695.

Start Signature

Daniel R. Petersen,

Deputy General Counsel.

End Signature End Further Info End Preamble

[FR Doc. 2011-20422 Filed 8-10-11; 8:45 am]

BILLING CODE 3180-W1-P